ALZAMEND NEURO INC (ALZN) Stock Analyst Earnings Estimates
NASDAQ:ALZN - Nasdaq - US02262M5067 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 322.64% | N/A 72.64% | N/A 47.44% | ||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | -12.32M | -14.85M -20.54% | -9.887M 33.42% | -4.446M 55.03% | N/A -166.12% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.01M | -4.42M 11.78% | -4.95M -11.99% | -12.32M -148.89% | -14.87M -20.70% | -9.938M 33.17% | -4.497M 54.75% | N/A -152.04% | N/A -73.07% | N/A -36.07% | N/A 75.00% | N/A 1,196.38% | N/A 115.88% | N/A 59.71% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -202.50 -17.65% | -247.95 -22.44% | N/A 94.04% | N/A 24.22% | N/A 33.61% | N/A 3.70% | N/A 75.64% | N/A 1,210.53% | N/A 104.27% | N/A 54.06% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -3.76 66.54% | -3.76 -10.05% | -3.95 -130.84% | -3.95 -14.67% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | -2.754M -189.99% | -2.856M -114.30% | -3.06M -206.21% | -3.162M -190.57% |
| EBIT Q2Q % growth | -2.856M -196.76% | -2.958M -117.80% | -3.162M -204.80% | -3.264M -186.59% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -1.71 95.00% | -3.26 | 1.55 | 47.53% |
| Q2 2025 Q2Q % growth | -3.42 91.36% | -3.49 | 0.07 | 1.96% |
| Q1 2025 Q2Q % growth | -11.25 79.17% | -21.85 | 10.60 | 48.51% |
| Q4 2024 Q2Q % growth | -120.15 -196.67% | -25.25 | -94.91 | -375.94% |
| Q3 2024 Q2Q % growth | -34.20 57.78% | -29.84 | -4.37 | -14.63% |
| Q2 2024 Q2Q % growth | -39.60 2.22% | -61.97 | 22.37 | 36.09% |
| Q1 2024 Q2Q % growth | -54.00 -33.33% | -48.20 | -5.81 | -12.04% |
| Q4 2023 Q2Q % growth | -40.50 25.00% | -61.97 | 21.47 | 34.64% |
| Q3 2023 Q2Q % growth | -81.00 -100.00% | -55.08 | -25.92 | -47.06% |
| Q2 2023 Q2Q % growth | -40.50 25.00% | -55.08 | 14.58 | 26.47% |
| Q1 2023 Q2Q % growth | -40.50 | -96.39 | 55.89 | 57.98% |
| Q4 2022 Q2Q % growth | -54.00 | -41.31 | -12.69 | -30.72% |
| Q3 2022 Q2Q % growth | -40.50 | -27.54 | -12.96 | -47.06% |
| Q2 2022 Q2Q % growth | -54.00 | -34.43 | -19.58 | -56.86% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -800% | 0% | -800% |
| Revenue | N/A | N/A | N/A | N/A |